November 2008 Research News

Breast Cancer Benefit Seen for Bevacizumab Combo
November 24, 2008
The combination of Xeloda (chemical name: capecitabine) and Avastin (chemical name: bevacizumab) has been shown to stop metastatic breast cancer from growing longer than Xeloda alone. Read more...

One-Fifth of Screening-Detected Breast Cancers May Have Been Safe to Ignore
November 24, 2008
A Norwegian study suggests that some breast cancers may go away without treatment, but the hypothesis is controversial and the results should be carefully considered. Read more...

Outcomes Differ with Type of Post-Mastectomy Breast Reconstruction
November 24, 2008
A small study suggests that reconstruction done immediately after mastectomy using tissue from the body offers better results after radiation compared to immediate reconstruction using implants. Read more...

Bone Loss in Breast Cancer Therapy May Involve More Than Drugs
November 21, 2008
A small study shows that other factors besides breast cancer treatment contribute to bone loss in post-menopausal women. Read more...

Bevacizumab Increases VTE Risk
November 18, 2008
New research suggests that Avastin increases the risk of a blood clot in a vein, but the risk varies depending on the type of cancer being treated. Read more...

Vitamin D Plus Calcium Does Not Cut Breast Cancer Risk
November 11, 2008
Results from the Women's Health Initiative study suggest that vitamin D and calcium supplements don't lower breast cancer risk. Read more...

Migraine May Be Associated with Reduced Breast Cancer Risk
November 6, 2008
Women who get migraine headaches appear to have a lower risk of breast cancer compared to women who don't get migraines. Read more...